[go: up one dir, main page]

SE9704723D0 - Ligands - Google Patents

Ligands

Info

Publication number
SE9704723D0
SE9704723D0 SE9704723A SE9704723A SE9704723D0 SE 9704723 D0 SE9704723 D0 SE 9704723D0 SE 9704723 A SE9704723 A SE 9704723A SE 9704723 A SE9704723 A SE 9704723A SE 9704723 D0 SE9704723 D0 SE 9704723D0
Authority
SE
Sweden
Prior art keywords
ligands
intercalative
partly
agents
fomula
Prior art date
Application number
SE9704723A
Other languages
English (en)
Inventor
Ulrica Sehlstedt
Palok Aich
Jan Bergman
Hans Vallberg
Bengt Norden
Astrid Graeslund
Original Assignee
Leif J I Lundblad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leif J I Lundblad filed Critical Leif J I Lundblad
Priority to SE9704723A priority Critical patent/SE9704723D0/sv
Publication of SE9704723D0 publication Critical patent/SE9704723D0/sv
Priority to PCT/SE1998/002340 priority patent/WO1999030712A1/en
Priority to IL13652598A priority patent/IL136525A0/xx
Priority to EP98963727A priority patent/EP1037638A1/en
Priority to JP2000538695A priority patent/JP2002508325A/ja
Priority to AU18990/99A priority patent/AU1899099A/en
Priority to APAP/P/2000/001835A priority patent/AP2000001835A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
SE9704723A 1997-12-17 1997-12-17 Ligands SE9704723D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9704723A SE9704723D0 (sv) 1997-12-17 1997-12-17 Ligands
PCT/SE1998/002340 WO1999030712A1 (en) 1997-12-17 1998-12-16 Agents
IL13652598A IL136525A0 (en) 1997-12-17 1998-12-16 Agents
EP98963727A EP1037638A1 (en) 1997-12-17 1998-12-16 Agents
JP2000538695A JP2002508325A (ja) 1997-12-17 1998-12-16 薬 剤
AU18990/99A AU1899099A (en) 1997-12-17 1998-12-16 Agents
APAP/P/2000/001835A AP2000001835A0 (en) 1997-12-17 1998-12-16 Agents.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704723A SE9704723D0 (sv) 1997-12-17 1997-12-17 Ligands

Publications (1)

Publication Number Publication Date
SE9704723D0 true SE9704723D0 (sv) 1997-12-17

Family

ID=20409439

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704723A SE9704723D0 (sv) 1997-12-17 1997-12-17 Ligands

Country Status (7)

Country Link
EP (1) EP1037638A1 (sv)
JP (1) JP2002508325A (sv)
AP (1) AP2000001835A0 (sv)
AU (1) AU1899099A (sv)
IL (1) IL136525A0 (sv)
SE (1) SE9704723D0 (sv)
WO (1) WO1999030712A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022002898A1 (en) * 2020-06-29 2022-01-06 Vironova Medical Ab 6h-indolo(2,3-b)quinoxaline derivatives useful in therapy in particular in a virus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600260D0 (sv) * 1986-01-21 1986-01-21 Lundblad Leif Substituerade indolokinoxaliner
SE504289C2 (sv) * 1994-06-23 1996-12-23 Leif J I Lundblad Användning av vissa indolo-2,3b-kinoxaliner för framställning av ett läkemedel för inhibering av enzymet HIV-integras
SE504862C2 (sv) * 1994-12-27 1997-05-20 Leif J I Lundblad Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler

Also Published As

Publication number Publication date
WO1999030712A1 (en) 1999-06-24
AP2000001835A0 (en) 2000-06-30
EP1037638A1 (en) 2000-09-27
AU1899099A (en) 1999-07-05
JP2002508325A (ja) 2002-03-19
IL136525A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
DE69819167D1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
EP0339842A3 (en) Novel oligoribonucleotide derivatives and application thereof to antiviral agents
CR6540A (es) Trifluorobutenos nematicidas
ZA983055B (en) Fungicidal trifluorophenyl-triazolopyrimidines.
DE69835201D1 (en) Neoglycoproteine
DE69534300D1 (de) Neues multimerisierendes reagenz
TR199902552T2 (xx) Fungisidal triflorometilalkilamino-triazolopirimidinler.
FR2715847B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
WO1999014346A3 (en) SENSE mRNA THERAPY
EP1123414A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF INTEGRIN ALPHA 4
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
ATE258930T1 (de) Dihydrobenzifurane
EP1077218A3 (en) Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
NZ501492A (en) Di-amine and tetra-amine derivatives and pharmaceuticals thereof, useful for treating cardiac arrhythmia
EP1163373A4 (en) ANTISENSE MODULATION OF THE CELLULAR INHIBITANT OF THE APOPTOSIS EXPRESSION
TR199701202T1 (xx) Yeni hidroksimik asit t�revleri.
SE9704723D0 (sv) Ligands
Green Traditional norms of masculinity
BR9801143A (pt) Copolìmeros de bloco de siloxano inovativos com espaçamento rìgidos e uso dos mesmos.
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
BR9807785A (pt) Processo para a preparação do composto, e, composto
ZA983231B (en) Substituted benzyloxyimino compounds.
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
EP0358432A3 (en) 1,4-dihydropyridine derivatives